HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN CARCINOGENESIS AND THE ROLE OF PROPHYLACTIC VACCINATION: A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6631Keywords:
Human Papillomavirus, Carcinogenesis, Oropharyngeal Cancer, Cervical Cancer, HPV Vaccination, Cancer PreventionAbstract
Human papillomavirus (HPV) is among the most prevalent sexually transmitted pathogens worldwide and an established cause of both benign proliferative lesions and malignant neoplasms. This narrative review examines the role of HPV infection in carcinogenesis at the principal anatomical sites involved and evaluates the contribution of prophylactic vaccination to disease control. A structured search of PubMed/MEDLINE, Scopus, and Web of Science was conducted for English-language publications available up to August 2026, supplemented by current guidance from international health authorities. The evidence confirms a causal role for high-risk genotypes, principally HPV-16 and HPV-18, in oropharyngeal squamous cell carcinoma and in cancers of the cervix, vulva, vagina, penis, and anus, mediated by the E6 and E7 oncoproteins through inactivation of the p53 and retinoblastoma pathways. The strength of this association is markedly site-dependent: it is well established in the oropharynx, cervix, and anus, but remains equivocal in the oral cavity and larynx. In oropharyngeal carcinoma, HPV status is an independent prognostic factor and is incorporated into current staging. Vaccination substantially reduces infection, precancerous lesions, and cervical cancer incidence, with the greatest benefit among individuals immunized before sexual debut. Vaccination and organized screening are complementary rather than alternative strategies, and suboptimal uptake-as observed in Poland-remains the principal barrier to realizing the full preventive potential of available vaccines.
References
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., Kim, H., Axelrod, R., Silverman, C. C., Redmond, K. P., & Gillison, M. L. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. The New England Journal of Medicine, 363(1), 24–35. https://doi.org/10.1056/NEJMoa0912217
Azis, N. R. F., & Djawad, K. (2022). Successful treatment of giant condyloma acuminata in HIV-positive patient with a combination of ligation and 80% trichloroacetic acid. Dermatology Review/Przegląd Dermatologiczny, 109(1), 58–64. https://doi.org/10.5114/dr.2022.116734
Baral, S. K., Biswas, P., Kaium, M. A., Islam, M. A., Dey, D., Saber, M. A., Rahaman, T. I., Emran, T. B., Hasan, M. N., Jeong, M. K., Han, I., Rahman, M. A., & Kim, B. (2022). A comprehensive discussion in vaginal cancer based on mechanisms, treatments, risk factors and prevention. Frontiers in Oncology, 12, Article 883805. https://doi.org/10.3389/fonc.2022.883805
Bewley, S. (2022). HPV vaccination and cervical cancer screening. The Lancet, 399(10339), 1939. https://doi.org/10.1016/S0140-6736(22)00110-6
Bishop, J. A., Lewis, J. S., Jr., Rocco, J. W., & Faquin, W. C. (2015). HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Seminars in Diagnostic Pathology, 32(5), 344–351. https://doi.org/10.1053/j.semdp.2015.02.013
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
Chaturvedi, A. K., Engels, E. A., Anderson, W. F., & Gillison, M. L. (2008). Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. Journal of Clinical Oncology, 26(4), 612–619. https://doi.org/10.1200/JCO.2007.14.1713
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., Liu, L., Lynch, C. F., Wentzensen, N., Jordan, R. C., Altekruse, S., Anderson, W. F., Rosenberg, P. S., & Gillison, M. L. (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology, 29(32), 4294–4301. https://doi.org/10.1200/JCO.2011.36.4596
Clarke, M. A., Deshmukh, A. A., Suk, R., Roberts, J., Gilson, R., Jay, N., Stier, E. A., & Wentzensen, N. (2022). A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups. International Journal of Cancer, 151(11), 1889–1901. https://doi.org/10.1002/ijc.34199
Conde-Ferráez, L., & González-Losa, M. del R. (2024). Multifocal epithelial hyperplasia: An understudied infectious disease affecting ethnic groups. A mini review. Frontiers in Cellular and Infection Microbiology, 14, Article 1420298. https://doi.org/10.3389/fcimb.2024.1420298
Cruickshank, M. E., & Grigore, M. (2021). Cervical cancers avoided by HPV immunisation. The Lancet, 398(10316), 2053–2055. https://doi.org/10.1016/S0140-6736(21)02396-5
Cuzick, J. (2015). Gardasil 9 joins the fight against cervix cancer. Expert Review of Vaccines, 14(8), 1047–1049. https://doi.org/10.1586/14760584.2015.1051470
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017). Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer, 141(4), 664–670. https://doi.org/10.1002/ijc.30716
Drolet, M., Bénard, É., Pérez, N., Brisson, M., & HPV Vaccination Impact Study Group. (2019). Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis. The Lancet, 394(10197), 497–509. https://doi.org/10.1016/S0140-6736(19)30298-3
Ebrahimi, F., Rasizadeh, R., Jafari, S., & Baghi, H. B. (2024). Prevalence of HPV in anal cancer: Exploring the role of infection and inflammation. Infectious Agents and Cancer, 19(1), Article 63. https://doi.org/10.1186/s13027-024-00624-0
Engelsgjerd, J. S., Leslie, S. W., & LaGrange, C. A. (2024). Penile cancer and penile intraepithelial neoplasia. In StatPearls. StatPearls Publishing.
Erlandson, M., Wertz, M. C., & Rosenfeld, E. (2023). Common skin conditions during pregnancy. American Family Physician, 107(2), 152–158.
Falcaro, M., Castañon, A., Ndlela, B., Checchi, M., Soldan, K., Lopez-Bernal, J., Elliss-Brookes, L., & Sasieni, P. (2021). The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study. The Lancet, 398(10316), 2084–2092. https://doi.org/10.1016/S0140-6736(21)02178-4
Ferreli, F., Di Bari, M., Moya-Plana, A., Canzano, F., Morenghi, E., De Virgilio, A., Mercante, G., Spriano, G., & Colombo, G. (2022). Association between human papillomavirus infection and malignant transformation of sinonasal inverted papilloma: A systematic review and meta-analysis. American Journal of Otolaryngology, 43(6), Article 103614. https://doi.org/10.1016/j.amjoto.2022.103614
Fife, K. H., Wheeler, C. M., Koutsky, L. A., Barr, E., Brown, D. R., Schiff, M. A., Kiviat, N. B., Jansen, K. U., Barber, H., Smith, J. F., Tadesse, A., Giacoletti, K., Smith, P. R., Suhr, G., & Johnson, D. A. (2004). Dose-ranging studies of the safety and immunogenicity of human papillomavirus type 11 and type 16 virus-like particle candidate vaccines in young healthy women. Vaccine, 22(21–22), 2943–2952. https://doi.org/10.1016/j.vaccine.2003.11.058
Fonsêca, T. C., Jural, L. A., Marañón-Vásquez, G. A., Magno, M. B., Roza, A. L. O. C., Ferreira, D. M. T. P., Maia, L. C., Romañach, M. J., Agostini, M., & Abrahão, A. C. (2024). Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis. Clinical Oral Investigations, 28(1), Article 62. https://doi.org/10.1007/s00784-023-05425-0
Gillison, M. L., & Shah, K. V. (2001). Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Current Opinion in Oncology, 13(3), 183–188. https://doi.org/10.1097/00001622-200105000-00009
Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., & Sidransky, D. (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute, 92(9), 709–720. https://doi.org/10.1093/jnci/92.9.709
Gillison, M. L., D’Souza, G., Westra, W., Sugar, E., Xiao, W., Begum, S., & Viscidi, R. (2008). Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Journal of the National Cancer Institute, 100(6), 407–420. https://doi.org/10.1093/jnci/djn025
Gustafson, P., Fenster, H. N., & So, A. I. (2014). Urethral squamous cell papilloma: Case report and literature review. Canadian Urological Association Journal, 8(5–6), E364–E365. https://doi.org/10.5489/cuaj.1582
Hernandez, B. Y., Goodman, M. T., Unger, E. R., Steinau, M., Powers, A., Lynch, C. F., Cozen, W., Saber, M. S., Peters, E. S., Wilkinson, E. J., Copeland, G., Hopenhayn, C., Huang, Y., Watson, M., Altekruse, S. F., Lyu, C., Saraiya, M., & HPV Typing of Cancer Workgroup. (2014). Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population. Frontiers in Oncology, 4, Article 9. https://doi.org/10.3389/fonc.2014.00009
Huang, S. H., Jacinto, J. C. K., O’Sullivan, B., Su, J., Kim, J., Ringash, J., Spreafico, A., Yu, E., Perez-Ordonez, B., Weinreb, I., Cho, J., Hope, A. J., Bratman, S. V., Giuliani, M. E., Hosni, A., Hahn, E., Goldstein, D. P., Tong, L., Eng, L., . . . Waldron, J. N. (2022). Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer, 128(15), 2908–2921. https://doi.org/10.1002/cncr.34266
Huh, W. K., Joura, E. A., Giuliano, A. R., Iversen, O.-E., de Andrade, R. P., Ault, K. A., Bartholomew, D., Cestero, R. M., Fedrizzi, E. N., Hirschberg, A. L., Mayrand, M.-H., Ruiz-Sternberg, A. M., Stapleton, J. T., Wiley, D. J., Ferenczy, A., Kurman, R., Ronnett, B. M., Stoler, M. H., Cuzick, J., . . . Luxembourg, A. (2017). Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: A randomised, double-blind trial. The Lancet, 390(10108), 2143–2159. https://doi.org/10.1016/S0140-6736(17)31821-4
Irshad, U., & Puckett, Y. (2023). Giant condylomata acuminata of Buschke and Löwenstein. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560714/
Jacobsen, I. M., Fenger Carlander, A. L., Aakilde, M., & von Buchwald, C. (2025). Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: A systematic review. Acta Oto-Laryngologica, 145(1), 66–71.
Jankowski, M., Grudziąż-Sękowska, J., Wrześniewska-Wal, I., Tyszko, P., Sękowski, K., Ostrowski, J., Gujski, M., & Pinkas, J. (2023). National HPV vaccination program in Poland-Public awareness, sources of knowledge, and willingness to vaccinate children against HPV. Vaccines, 11(8), Article 1371. https://doi.org/10.3390/vaccines11081371
Jensen, J. E., Becker, G. L., Jackson, J. B., & Rysavy, M. B. (2024). Human papillomavirus and associated cancers: A review. Viruses, 16(5), Article 680. https://doi.org/10.3390/v16050680
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiology, Biomarkers & Prevention, 14(2), 467–475. https://doi.org/10.1158/1055-9965.EPI-04-0551
Lechien, J. R., & Hans, S. (2023). Epidemiological, clinical and oncological outcomes of laryngeal verrucous carcinomas: A systematic review. Journal of Otolaryngology – Head & Neck Surgery, 52(1), Article 81. https://doi.org/10.1186/s40463-023-00666-1
Leslie, S. W., Sajjad, H., & Kumar, S. (2025). Condylomata acuminata (genital warts). In StatPearls. StatPearls Publishing.
Li, W., Zhai, L., Zhu, Y., Lou, F., Liu, S., Li, K., Chen, L., & Wang, H. (2024). Review effects of radiation treatment on HPV-related vulvar cancer: A meta-analysis and systematic review. Frontiers in Oncology, 14, Article 1400047. https://doi.org/10.3389/fonc.2024.1400047
Li, Z., Liu, P., Wang, Z., Zhang, Z., Chen, Z., Chu, R., Li, G., Han, Q., Zhao, Y., Li, L., Miao, J., Kong, B., & Song, K. (2023). Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: A systematic review and meta-analysis. The Lancet Oncology, 24(4), 403–414. https://doi.org/10.1016/S1470-2045(23)00066-9
Loopik, D. L., Bentley, H. A., Eijgenraam, M. N., IntHout, J., Bekkers, R. L. M., & Bentley, J. R. (2021). The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: A systematic review and meta-analysis. Journal of Lower Genital Tract Disease, 25(3), 221–231. https://doi.org/10.1097/LGT.0000000000000604
Lu, Y., Li, P., Luo, G., Liu, D., & Zou, H. (2020). Cancer attributable to human papillomavirus infection in China: Burden and trends. Cancer, 126(16), 3719–3732. https://doi.org/10.1002/cncr.32986
Lydiatt, W. M., Patel, S. G., O’Sullivan, B., Brandwein, M. S., Ridge, J. A., Migliacci, J. C., Loomis, A. M., & Shah, J. P. (2017). Head and neck cancers-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians, 67(2), 122–137. https://doi.org/10.3322/caac.21389
McCormick, J. P., Suh, J. D., Lee, J. T., Wells, C., & Wang, M. B. (2022). Role of high-risk HPV detected by PCR in malignant sinonasal inverted papilloma: A meta-analysis. The Laryngoscope, 132(5), 926–932. https://doi.org/10.1002/lary.29735
Mehanna, H., Beech, T., Nicholson, T., El-Hariry, I., McConkey, C., Paleri, V., & Roberts, S. (2013). Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-Systematic review and meta-analysis of trends by time and region. Head & Neck, 35(5), 747–755. https://doi.org/10.1002/hed.22015
Menon, S., Moch, H., Berney, D. M., Cree, I. A., Srigley, J. R., Tsuzuki, T., Compérat, E., Hartmann, A., Netto, G., Rubin, M. A., Gill, A. J., Turajlic, S., Tan, P. H., Raspollini, M. R., Tickoo, S. K., & Amin, M. B. (2023). WHO 2022 classification of penile and scrotal cancers: Updates and evolution. Histopathology, 82(4), 508–520. https://doi.org/10.1111/his.14824
Michalek, I. M., Koczkodaj, P., & Didkowska, J. (2024). National launch of human papillomavirus (HPV) immunization program in Poland, 2023. Vaccine: X, 17, Article 100436. https://doi.org/10.1016/j.jvacx.2024.100436
Mix, J. M., Gopalani, S. V., Simko, S., & Saraiya, M. (2022). Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001–2017. Preventive Medicine, 164, Article 107302. https://doi.org/10.1016/j.ypmed.2022.107302
Monie, A., Hung, C.-F., Roden, R., & Wu, T.-C. (2008). Cervarix: A vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics: Targets and Therapy, 2(1), 97–105.
Mwaka, A. D., Orach, C. G., Were, E. M., Lyratzopoulos, G., Wabinga, H., & Roland, M. (2016). Awareness of cervical cancer risk factors and symptoms: Cross-sectional community survey in post-conflict northern Uganda. Health Expectations, 19(4), 854–867. https://doi.org/10.1111/hex.12382
Narodowy Fundusz Zdrowia. (n.d.). Profilaktyka na NFZ – Program profilaktyki raka szyjki macicy [Prevention under the National Health Fund – Cervical cancer prevention programme]. Retrieved August 4, 2026, from https://www.nfz.gov.pl/dla-pacjenta/programy-profilaktyczne/
Olawaiye, A. B., Cuello, M. A., Beriwal, S., & Rogers, L. J. (2025). Cancer of the vulva: 2025 update: FIGO Cancer Report 2025. International Journal of Gynecology & Obstetrics, 171(Suppl. 1), 36–47. https://doi.org/10.1002/ijgo.70390
Olesen, T. B., Sand, F. L., Rasmussen, C. L., Albieri, V., Toft, B. G., Norrild, B., Munk, C., & Kjær, S. K. (2019). Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: A systematic review and meta-analysis. The Lancet Oncology, 20(1), 145–158. https://doi.org/10.1016/S1470-2045(18)30682-X
Ostör, A. G. (1993). Natural history of cervical intraepithelial neoplasia: A critical review. International Journal of Gynecological Pathology, 12(2), 186–192.
Quinlan, J. D. (2021). Human papillomavirus: Screening, testing, and prevention. American Family Physician, 104(2), 152–159.
Ramos-Gregorio, C. O., Tremillo-Maldonado, O., Silveira, F., Schuch, L. F., Pereira-Prado, V., Sicco, E., Soto-Najera, A. C., Gómez-Palacio-Gastélum, M., Isiordia-Espinoza, M., Muñoz-Ibarra, J. J., Toral-Rizo, V., & Bologna-Molina, R. (2025). Multifocal epithelial hyperplasia: Clinical features, diagnosis and management challenges. World Journal of Experimental Medicine, 15(4), Article 114368. https://doi.org/10.5493/wjem.v15.i4.114368
Rasmussen, C. L., Bertoli, H. K., Sand, F. L., Kjaer, A. K., Thomsen, L. T., & Kjaer, S. K. (2021). The prognostic significance of HPV, p16, and p53 protein expression in vaginal cancer: A systematic review. Acta Obstetricia et Gynecologica Scandinavica, 100(12), 2144–2156. https://doi.org/10.1111/aogs.14260
Rees, C. P., Brhlikova, P., & Pollock, A. M. (2020). Will HPV vaccination prevent cervical cancer? Journal of the Royal Society of Medicine, 113(2), 64–78. https://doi.org/10.1177/0141076819899308
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., Copeland, G., Cozen, W., Peters, E. S., Huang, Y., Saber, M. S., Altekruse, S., Goodman, M. T., & HPV Typing of Cancers Workgroup. (2015). US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute, 107(6), Article djv086. https://doi.org/10.1093/jnci/djv086
Sasieni, P., & Cuzick, J. (2020). Population-level impact of human papillomavirus vaccination. The Lancet, 395(10222), 412. https://doi.org/10.1016/S0140-6736(19)33109-5
Sauter, M., Keilholz, G., Kranzbühler, H., Lombriser, N., Prakash, M., Vavricka, S. R., & Misselwitz, B. (2016). Presenting symptoms predict local staging of anal cancer: A retrospective analysis of 86 patients. BMC Gastroenterology, 16, Article 46. https://doi.org/10.1186/s12876-016-0461-0
Sechi, I., Muresu, N., Di Lorenzo, B., Saderi, L., Puci, M., Aliberti, S., Maida, I., Mondoni, M., Piana, A., & Sotgiu, G. (2024). Pulmonary involvement in recurrent respiratory papillomatosis: A systematic review. Infectious Disease Reports, 16(2), 200–215. https://doi.org/10.3390/idr16020016
Sun, J. X., Xu, J. Z., Liu, C. Q., An, Y., Xu, M. Y., Zhong, X. Y., Zeng, N., Ma, S. Y., He, H. D., Hu, J., Liu, Z., Wang, S. G., & Xia, Q. D. (2023). The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample Mendelian randomization. Journal of Medical Virology, 95(1), Article e28208. https://doi.org/10.1002/jmv.28208
Tamboon, E., Sihavong, P., Kitkumthorn, N., Bumalee, D., Arayapisit, T., & Lapthanasupkul, P. (2022). Association of HPV and EBV in oral verrucous squamous cell carcinoma and oral verrucous hyperplasia. Journal of the Medical Association of Thailand, 105(2), 367–372.
Wang, X., Li, J., Li, X., & Huang, C. (2026). Efficacy and safety of photodynamic therapy for vaginal intraepithelial neoplasia: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy, 58, Article 105340. https://doi.org/10.1016/j.pdpdt.2026.105340
Welschmeyer, A., & Berke, G. S. (2021). An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis. Laryngoscope Investigative Otolaryngology, 6(2), 226–233.
Włoszek, E., Krupa, K., Skrok, E., Budzik, M. P., Deptała, A., & Badowska-Kozakiewicz, A. (2025). HPV and cervical cancer-Biology, prevention, and treatment updates. Current Oncology, 32(3), Article 122. https://doi.org/10.3390/curroncol32030122
Wolf, J., Kist, L. F., Pereira, S. B., Quessada, M. A., Petek, H., Pille, A., Maccari, J. G., Mutlaq, M. P., & Nasi, L. A. (2024). Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Reviews in Medical Virology, 34(3), Article e2537. https://doi.org/10.1002/rmv.2537
World Health Organization. (2009). Human papillomavirus vaccines: WHO position paper. Weekly Epidemiological Record, 84(15), 118–131.
World Health Organization. (2026, July 3). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
Yanofsky, V. R., Patel, R. V., & Goldenberg, G. (2012). Genital warts: A comprehensive review. The Journal of Clinical and Aesthetic Dermatology, 5(6), 25–36.
Yoshikawa, H. (2008). Cervical HPV infection: Epidemiology and vaccination [In Japanese]. Kansenshogaku Zasshi, 82(6), 609–612. https://doi.org/10.11150/kansenshogakuzasshi1970.82.609
Zhao, R. W., Guo, Z. Q., & Zhang, R. X. (2016). Human papillomavirus infection and the malignant transformation of sinonasal inverted papilloma: A meta-analysis. Journal of Clinical Virology, 79, 36–43. https://doi.org/10.1016/j.jcv.2016.04.001
zur Hausen, H. (2002). Papillomaviruses and cancer: From basic studies to clinical application. Nature Reviews Cancer, 2(5), 342–350. https://doi.org/10.1038/nrc798
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Kinga Bukała, Anton Osnytskyy, Kamil Rutkowski, Magdalena Ślifierska, Daria Furman, Karina Udrycka, Szymon Klimaszewski
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
